2026 Q3 Portfolio Activity
In 2026 Q3, Ishara Investments LP maintained a portfolio of 56 distinct positions. The most significant new addition was TARSUS PHARMACEUTICALS INC, now representing 4.55% of the total fund value. They heavily accumulated shares in CYTOKINETICS INC, increasing the position by 290.2%. Conversely, Ishara Investments LP completely exited their position in AGIOS PHARMACEUTICALS INC.
Position History
hover any row below to update
Loading…
Ishara Investments LP
AUM $120M
Total Positions
56
Quarter
2026 Q3
Top Holding
TVTX (7.1%)
Top 10 Concentration
49.6%
Turnover Rate
23.4%
Sector HHI
0.18
Items per page:
Showing 1-50 of 56
Ishara Investments LP Full Holdings List — 2026 Q3
| Stock | History | Sector / Type | Port % | Prev % | Rank / Prev | Conviction | Change | % Change | Influence | Shares | Mkt Value | Avg Cost | Price Held | 1st Owned | Source | Source Date | Date Reported | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
TVTX
TRAVERE THERAPE...
|
Healthcare | 7.06% | 3.42% |
#1
11
Prev: #12
|
7.8 |
—
|
63,000 | 76.8% |
P
S
|
145,000 | $8,537,600 |
$40.29
+26.8%
|
2026 Q1 | 13F Filing | 2026-09-30 | 2026-11-16 | ||
|
CYTK
CYTOKINETICS IN...
|
Healthcare | 6.97% | 2.05% |
#2
19
Prev: #21
|
7.3 |
—
|
95,200 | 290.2% |
P
S
|
128,000 | $8,436,480 |
$70.85
-27.6%
|
2026 Q2 | 13F Filing | 2026-09-30 | 2026-11-16 | ||
|
BBIO
BRIDGEBIO PHARM...
|
Healthcare | 5.44% | 3.14% |
#3
11
Prev: #14
|
6.2 |
—
|
42,600 | 74.2% |
P
S
|
100,000 | $6,580,000 |
$71.51
+8.6%
|
2025 Q4 | 13F Filing | 2026-09-30 | 2026-11-16 | ||
|
ACAD
ACADIA PHARMACE...
|
Healthcare | 5.33% | 7.62% |
#4
3
Prev: #1
|
2.6 |
—
|
-90,000 | -22.0% |
P
S
|
320,000 | $6,448,000 | 2025 Q4 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
TARS
TARSUS PHARMACE...
|
Healthcare | 4.55% | — |
#5
Prev: #—
|
5.8 |
—
|
70,000 | — |
NEW
|
70,000 | $5,502,700 | 2025 Q4 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
PTCT
PTC THERAPEUTIC...
|
Healthcare | 4.28% | — |
#6
Prev: #—
|
5.2 |
—
|
80,000 | — |
NEW
|
80,000 | $5,182,400 | 2025 Q4 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
PRAX
PRAXIS PRECISIO...
|
Healthcare | 4.09% | 5.55% |
#7
3
Prev: #4
|
1.6 |
—
|
-5,550 | -24.6% |
P
S
|
17,000 | $4,950,910 | 2025 Q4 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
VERA
VERA THERAPEUTI...
|
Healthcare | 4.00% | 0.32% |
#8
30
Prev: #38
|
4.6 |
—
|
139,750 | 1363.4% |
P
S
|
150,000 | $4,843,500 | 2026 Q1 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
ARQT
ARCUTIS BIOTHER...
|
Healthcare | 3.93% | — |
#9
Prev: #—
|
5.1 |
—
|
180,000 | — |
NEW
|
180,000 | $4,757,400 | 2025 Q4 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
ANNX
ANNEXON INC
|
Healthcare | 3.92% | 3.44% |
#10
1
Prev: #11
|
4.1 |
—
|
300,000 | 36.6% |
P
S
|
1,120,000 | $4,737,600 | 2025 Q4 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
UTHR
UNITED THERAPEU...
|
Healthcare | 3.58% | — |
#11
Prev: #—
|
4.9 |
—
|
8,000 | — |
NEW
|
8,000 | $4,335,120 | 2025 Q4 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
NAMS
NEWAMSTERDAM PH...
|
Healthcare | 3.22% | 0.92% |
#12
21
Prev: #33
|
4.3 |
—
|
123,100 | 333.6% |
P
S
|
160,000 | $3,891,200 | 2025 Q4 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
XERS
XERIS BIOPHARMA...
|
Healthcare | 3.16% | 7.16% |
#13
11
Prev: #2
|
1.3 |
—
|
-830,000 | -67.5% |
P
S
|
400,000 | $3,824,000 | 2025 Q4 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
CELC
CELCUITY INC
|
Healthcare | 3.15% | — |
#14
Prev: #—
|
4.8 |
—
|
48,000 | — |
NEW
|
48,000 | $3,816,960 | 2026 Q3 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
DBVT
DBV TECHNOLOGIE...
|
Healthcare | 2.62% | 2.22% |
#15
4
Prev: #19
|
3.5 |
—
|
85,500 | 46.3% |
P
S
|
270,000 | $3,175,200 | 2026 Q1 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
VRDN
VIRIDIAN THERAP...
|
Healthcare | 2.55% | — |
#16
Prev: #—
|
4.5 |
—
|
150,000 | — |
NEW
|
150,000 | $3,088,500 | 2026 Q3 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
ZNTL
ZENTALIS PHARMA...
|
Healthcare | 2.47% | 3.65% |
#17
8
Prev: #9
|
3.0 |
—
|
55,000 | 5.4% |
P
S
|
1,080,000 | $2,991,600 | 2025 Q4 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
BMRN
BIOMARIN PHARMA...
|
Healthcare | 2.38% | 6.03% |
#18
15
Prev: #3
|
1.0 |
—
|
-95,500 | -66.6% |
P
S
|
48,000 | $2,880,000 | 2025 Q4 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
BIIB
BIOGEN INC
|
Healthcare | 2.24% | — |
#19
Prev: #—
|
4.4 |
—
|
12,000 | — |
NEW
|
12,000 | $2,710,560 | 2026 Q3 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
MLYS
MINERALYS THERA...
|
Healthcare | 2.08% | 2.03% |
#20
2
Prev: #22
|
1.3 |
—
|
-2,500 | -2.4% |
P
S
|
100,000 | $2,513,000 | 2026 Q1 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
LGND
LIGAND PHARMACE...
|
Healthcare | 2.07% | — |
#21
Prev: #—
|
4.3 |
—
|
8,000 | — |
NEW
|
8,000 | $2,498,960 | 2026 Q1 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
RARE
ULTRAGENYX PHAR...
|
Healthcare | 1.99% | 5.03% |
#22
17
Prev: #5
|
0.8 |
—
|
-45,000 | -22.0% |
P
S
|
160,000 | $2,404,800 | 2025 Q4 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
PCVX
VAXCYTE INC
|
Healthcare | 1.88% | 3.50% |
#23
13
Prev: #10
|
0.8 |
—
|
-42,000 | -51.2% |
P
S
|
40,000 | $2,276,000 | 2025 Q4 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
ORIC
ORIC PHARMACEUT...
|
Healthcare | 1.78% | 0.98% |
#24
8
Prev: #32
|
3.2 |
—
|
37,000 | 30.1% |
P
S
|
160,000 | $2,155,200 | 2025 Q4 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
AXSM
AXSOME THERAPEU...
|
Healthcare | 1.52% | 2.95% |
#25
10
Prev: #15
|
0.6 |
—
|
-6,400 | -39.0% |
P
S
|
10,000 | $1,843,900 | 2026 Q1 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
SLN
SILENCE THERAPE...
|
Healthcare | 1.45% | 1.79% |
#26
3
Prev: #23
|
3.6 |
—
|
104,650 | 189.1% |
P
S
|
160,000 | $1,748,800 | 2025 Q4 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
BEAM
BEAM THERAPEUTI...
|
Healthcare | 1.41% | 1.03% |
#27
3
Prev: #30
|
3.6 |
—
|
29,000 | 70.7% |
P
S
|
70,000 | $1,711,500 | 2025 Q4 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
BHVN
BIOHAVEN LTD
|
Healthcare | 1.32% | — |
#28
Prev: #—
|
4.0 |
—
|
120,000 | — |
NEW
|
120,000 | $1,602,000 | 2025 Q4 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
RARE
PUT
ULTRAGENYX PHAR...
|
PUT Option | 1.24% | — |
#29
Prev: #—
|
4.0 |
—
|
1,000 | — |
NEW
|
1,000 | $1,503,000 | 2025 Q4 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
CTNM
CONTINEUM THERA...
|
Healthcare | 1.20% | 2.47% |
#30
14
Prev: #16
|
0.5 |
—
|
-97,000 | -47.3% |
P
S
|
108,000 | $1,449,360 | 2026 Q1 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
GMAB
GENMAB A/S
|
Healthcare | 1.18% | 2.07% |
#31
11
Prev: #20
|
0.5 |
—
|
-62,500 | -61.0% |
P
S
|
40,000 | $1,427,000 | 2025 Q4 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
NBIX
NEUROCRINE BIOS...
|
Healthcare | 0.94% | — |
#32
Prev: #—
|
3.9 |
—
|
8,000 | — |
NEW
|
8,000 | $1,134,720 | 2026 Q3 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
MNPR
MONOPAR THERAPE...
|
Healthcare | 0.79% | 0.84% |
#33
3
Prev: #36
|
0.8 |
—
|
-300 | -2.4% |
P
S
|
12,000 | $956,040 | 2026 Q2 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
MLTX
MOONLAKE IMMUNO...
|
Healthcare | 0.77% | — |
#34
Prev: #—
|
3.8 |
—
|
80,000 | — |
NEW
|
80,000 | $936,000 | 2026 Q1 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
SPRY
ARS PHARMACEUTI...
|
Healthcare | 0.71% | 0.84% |
#35
Prev: #35
|
2.8 |
—
|
56,510 | 39.4% |
P
S
|
200,000 | $862,000 | 2026 Q2 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
IONS
IONIS PHARMACEU...
|
Healthcare | 0.59% | — |
#36
Prev: #—
|
3.7 |
—
|
16,000 | — |
NEW
|
16,000 | $714,400 | 2026 Q3 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
OLMA
OLEMA PHARMACEU...
|
Healthcare | 0.57% | — |
#37
Prev: #—
|
3.7 |
—
|
80,000 | — |
NEW
|
80,000 | $691,200 | 2025 Q4 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
LXRX
LEXICON PHARMAC...
|
Healthcare | 0.50% | 2.24% |
#38
21
Prev: #17
|
0.2 |
—
|
-951,000 | -74.8% |
P
S
|
320,000 | $600,000 | 2025 Q4 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
WVE
WAVE LIFE SCIEN...
|
Healthcare | 0.49% | 1.40% |
#39
14
Prev: #25
|
0.2 |
—
|
-168,000 | -51.2% |
P
S
|
160,000 | $592,000 | 2026 Q2 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
SVRA
SAVARA INC
|
Healthcare | 0.34% | — |
#40
Prev: #—
|
3.6 |
—
|
80,000 | — |
NEW
|
80,000 | $412,800 | 2026 Q3 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
GOSS
GOSSAMER BIO IN...
|
Healthcare | 0.24% | 0.10% |
#41
Prev: #41
|
0.1 |
—
|
-796,000 | -97.1% |
P
S
|
24,000 | $284,400 | 2026 Q1 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
MREO
MEREO BIOPHARMA...
|
Healthcare | 0.00% | 0.18% |
Sold All 😨
(Was: #40) |
0.0 |
—
|
-768,750 | -100.0% |
CLOSED
|
— | $— | 2026 Q2 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
IMTX
IMMATICS N.V
|
Healthcare | 0.00% | 0.23% |
Sold All 😨
(Was: #39) |
0.0 |
—
|
-30,750 | -100.0% |
CLOSED
|
— | $— | 2025 Q4 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
ERAS
ERASCA INC
|
Healthcare | 0.00% | 0.55% |
Sold All 😨
(Was: #37) |
0.0 |
—
|
-41,000 | -100.0% |
CLOSED
|
— | $— | 2026 Q2 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
VRTX
VERTEX PHARMACE...
|
Healthcare | 0.00% | 0.90% |
Sold All 😨
(Was: #34) |
0.0 |
—
|
-2,460 | -100.0% |
CLOSED
|
— | $— | 2026 Q2 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
SION
SIONNA THERAPEU...
|
Healthcare | 0.00% | 0.99% |
Sold All 😨
(Was: #31) |
0.0 |
—
|
-123,000 | -100.0% |
CLOSED
|
— | $— | 2026 Q1 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
ALNY
ALNYLAM PHARMAC...
|
Healthcare | 0.00% | 1.13% |
Sold All 😨
(Was: #29) |
0.0 |
—
|
-5,125 | -100.0% |
CLOSED
|
— | $— | 2026 Q1 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
ELVN
ENLIVEN THERAPE...
|
Healthcare | 0.00% | 1.22% |
Sold All 😨
(Was: #28) |
0.0 |
—
|
-32,800 | -100.0% |
CLOSED
|
— | $— | 2026 Q2 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
SRRK
SCHOLAR ROCK HL...
|
Healthcare | 0.00% | 1.24% |
Sold All 😨
(Was: #27) |
0.0 |
—
|
-30,750 | -100.0% |
CLOSED
|
— | $— | 2026 Q1 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
NKTR
NEKTAR THERAPEU...
|
Healthcare | 0.00% | 1.37% |
Sold All 😨
(Was: #26) |
0.0 |
—
|
-26,650 | -100.0% |
CLOSED
|
— | $— | 2025 Q4 | 13F Filing | 2026-09-30 | 2026-11-16 |
Showing 1-50 of 56 holdings